Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy.
在接受甲氨蝶呤治疗但活动性类风湿关节炎患者中,使用依那西普和甲氨蝶呤或单独使用依那西普治疗期间血浆IL-6、血浆VEGF和血清YKL-40的变化
期刊:Biomarker Insights
影响因子:2.6
doi:10.4137/bmi.s2300
Knudsen Lene Surland, Hetland Merete Lund, Johansen Julia Sidenius, Skjødt Henrik, Peters Niels Daugaard, Colic Ada, Grau Karin, Nielsen Hans Jørgen, Ostergaard Mikkel